Indications
Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).
Composition
- Active substance
- bimatoprost
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lumigan
- Active substance
- bimatoprost
- ATC code
- S01EE03
- Group
- Sensory organs
- Therapeutic area
- Glaucoma, Open-Angle, Ocular Hypertension
- Marketing authorisation holder
- AbbVie Deutschland GmbH & Co. KG
- Status
- Authorised
- EU authorisation
- 8 Mar 2002